DENTSPLY SIRONA (NASDAQ:XRAY) PT Lowered to $28.00 at Evercore ISI

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price lowered by Evercore ISI from $35.00 to $28.00 in a research report sent to investors on Tuesday morning, Benzinga reports. The firm currently has an outperform rating on the medical instruments supplier’s stock.

A number of other analysts also recently issued reports on the company. Piper Sandler restated a neutral rating and issued a $32.00 price target (down from $35.00) on shares of DENTSPLY SIRONA in a research report on Friday, May 3rd. Leerink Partnrs reiterated an outperform rating on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. Barrington Research reduced their target price on DENTSPLY SIRONA from $41.00 to $38.00 and set an outperform rating on the stock in a research note on Friday, May 3rd. Needham & Company LLC reduced their target price on DENTSPLY SIRONA from $42.00 to $36.00 and set a buy rating on the stock in a research note on Friday, May 3rd. Finally, SVB Leerink assumed coverage on DENTSPLY SIRONA in a research note on Monday, February 26th. They issued an outperform rating and a $42.00 target price on the stock. Five equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, DENTSPLY SIRONA presently has an average rating of Moderate Buy and an average price target of $34.44.

DENTSPLY SIRONA Stock Up 0.5 %

NASDAQ XRAY opened at $25.29 on Tuesday. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.97 and a current ratio of 1.43. The company has a market capitalization of $5.25 billion, a P/E ratio of -57.48, a P/E/G ratio of 1.12 and a beta of 1.04. DENTSPLY SIRONA has a one year low of $24.82 and a one year high of $41.65. The stock has a 50 day moving average price of $27.83 and a 200-day moving average price of $31.77.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.42. The company had revenue of $953.00 million during the quarter, compared to the consensus estimate of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. DENTSPLY SIRONA’s revenue was down 2.6% on a year-over-year basis. During the same period last year, the company earned $0.39 earnings per share. As a group, equities analysts predict that DENTSPLY SIRONA will post 2.02 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 12th. Investors of record on Friday, June 28th will be given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 2.53%. The ex-dividend date of this dividend is Friday, June 28th. DENTSPLY SIRONA’s payout ratio is currently -145.45%.

Insiders Place Their Bets

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 3,577 shares of the stock in a transaction on Friday, May 31st. The stock was acquired at an average price of $27.95 per share, with a total value of $99,977.15. Following the completion of the acquisition, the director now owns 58,374 shares in the company, valued at $1,631,553.30. The acquisition was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 0.52% of the company’s stock.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of institutional investors and hedge funds have recently modified their holdings of the company. Vanguard Group Inc. lifted its holdings in shares of DENTSPLY SIRONA by 1.5% during the third quarter. Vanguard Group Inc. now owns 25,250,443 shares of the medical instruments supplier’s stock worth $862,555,000 after purchasing an additional 369,213 shares during the period. Nuance Investments LLC lifted its holdings in shares of DENTSPLY SIRONA by 30.4% during the fourth quarter. Nuance Investments LLC now owns 11,603,889 shares of the medical instruments supplier’s stock worth $412,982,000 after purchasing an additional 2,702,457 shares during the period. First Eagle Investment Management LLC raised its position in DENTSPLY SIRONA by 1.2% during the fourth quarter. First Eagle Investment Management LLC now owns 9,786,845 shares of the medical instruments supplier’s stock valued at $348,314,000 after acquiring an additional 120,508 shares in the last quarter. Wellington Management Group LLP raised its position in DENTSPLY SIRONA by 21.1% during the fourth quarter. Wellington Management Group LLP now owns 8,138,253 shares of the medical instruments supplier’s stock valued at $289,640,000 after acquiring an additional 1,419,503 shares in the last quarter. Finally, Cooke & Bieler LP raised its position in DENTSPLY SIRONA by 18.3% during the fourth quarter. Cooke & Bieler LP now owns 7,061,910 shares of the medical instruments supplier’s stock valued at $251,333,000 after acquiring an additional 1,092,922 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.